Skip to content

Antishivering effect of dexmedetomidine

Antishivering effect of dexmedetomidine in the adult patients undergoing VATs wedge resection : A comparision with placebo control group

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017101236728N1
Enrollment
40
Registered
2017-11-14
Start date
2016-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shivering.

Interventions

Intervention 1: Intervention group: receive either 1 µg/kg of dexmedetomidine 10 min after skin incision. Intervention 2: Control group: receive normal saline 10 min after skin incision.
Prevention
Placebo
Intervention group: receive either 1 µg/kg of dexmedetomidine 10 min after skin incision
Control group: receive normal saline 10 min after skin incision

Sponsors

Gil Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included adult patients (18-60 yrs) of American Society of Anesthesiologists physical status I who were scheduled for elective VATS wedge resection without previous VATS. The exclusion criteria were patient with allergy to any study medication, uncontrolled hypertension, heart-block greater than first degree, respiratory insufficiency, neuromuscular disorders, history of convulsions, thyroid disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Incidence of shivering. Timepoint: after the end of surgery. Method of measurement: observation.

Secondary

MeasureTime frame
Incidence of hypothermia. Timepoint: after the end of surgery. Method of measurement: body temperature.

Countries

Korea, Republic Of

Contacts

Public ContactJi Yeon Lee

Gachon University

easy95@gilhospital.com0082324603637

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026